Third, while our findings suggest that colchicine's therapeutic impact on ALI may be attributed to its anti-inflammatory properties and possibly involves the CXCL12/CXCR4 axis, we did not perform external validation. The gene discussed is CXCL12; the disease is acute respiratory distress syndrome.